Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cann

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
BMJ (Clinical Research Ed.)|June 26, 1993
Open access gastroscopy. Service is efficient and effectiveP A Cann, W A Corbett, M G Bramble, et al.
Journal of Virology|November 1, 1991
Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophagesB Chesebro, J Nishio, S Perryman, et al.
Annals of the New York Academy of Sciences|March 23, 1994
Loxiglumide, a CCK-A antagonist, in irritable bowel syndrome. A pilot multicenter clinical studyP A Cann, L C Rovati, H L Smart, et al.
Gut|October 1, 1982
Is the transit time of a meal through the small intestine related to the rate at which it leaves the stomach?N W Read, J Cammack, C Edwards, et al.
Journal of Gastroenterology and Hepatology|October 26, 1999
Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot studyJ P Watson, D E Jones, O F James, et al.
Lancet (London, England)|February 4, 1995
Is breast cancer a progressive or systemic disease?J P van Netten, A S Ross, S A Cann, et al.
The Journal of Biological Chemistry|November 25, 1991
Monoclonal antibodies to Escherichia coli ribosomal proteins L9 and L10. Effects on ribosome function and localization of L9 on the surface of the 50 S ribosomal subunitB Nag, S S Akella, P A Cann, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitisJ C Mansfield, M H Giaffer, P A Cann, et al.
Gut|May 1, 1989
Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind studyS S Rao, S A Dundas, C D Holdsworth, et al.
Atherosclerosis|April 1, 2008
Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-/- miceJennifer A Cann, Thomas C Register, Michael R Adams, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
BMJ (Clinical Research Ed.)|June 26, 1993
Open access gastroscopy. Service is efficient and effectiveP A Cann, W A Corbett, M G Bramble, et al.
Journal of Virology|November 1, 1991
Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophagesB Chesebro, J Nishio, S Perryman, et al.
Annals of the New York Academy of Sciences|March 23, 1994
Loxiglumide, a CCK-A antagonist, in irritable bowel syndrome. A pilot multicenter clinical studyP A Cann, L C Rovati, H L Smart, et al.
Gut|October 1, 1982
Is the transit time of a meal through the small intestine related to the rate at which it leaves the stomach?N W Read, J Cammack, C Edwards, et al.
Journal of Gastroenterology and Hepatology|October 26, 1999
Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot studyJ P Watson, D E Jones, O F James, et al.
Lancet (London, England)|February 4, 1995
Is breast cancer a progressive or systemic disease?J P van Netten, A S Ross, S A Cann, et al.
The Journal of Biological Chemistry|November 25, 1991
Monoclonal antibodies to Escherichia coli ribosomal proteins L9 and L10. Effects on ribosome function and localization of L9 on the surface of the 50 S ribosomal subunitB Nag, S S Akella, P A Cann, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitisJ C Mansfield, M H Giaffer, P A Cann, et al.
Gut|May 1, 1989
Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind studyS S Rao, S A Dundas, C D Holdsworth, et al.
Atherosclerosis|April 1, 2008
Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-/- miceJennifer A Cann, Thomas C Register, Michael R Adams, et al.
Pageof 9